# PACIRA BIOSCIENCES INC (PCRX)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/PCRX/

- Reporting holders: 6
- Reported value: $104.7K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $61.8K | 2,467 | 0.0% | 12 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $26.0K | 1,036 | 0.0% | 17 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $8.9K | 357 | 0.0% | 7 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $7.7K | 307 | 0.0% | 20 |
| [GILPIN WEALTH MANAGEMENT, LLC](https://holderbook.com/funds/2058144-gilpin-wealth-management-llc/) | $226 | 9 | 0.0% | 4 |
| [Davis Capital Management](https://holderbook.com/funds/1811806-davis-capital-management/) | $50 | 2 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 6 | $104.7K |
| Q2 2026 | 255 | $1.2B |
| Q1 2026 | 239 | $985.4M |
| Q4 2025 | 263 | $1.2B |
| Q3 2025 | 243 | $1.3B |
| Q2 2025 | 234 | $1.2B |
| Q1 2025 | 234 | $1.3B |
| Q4 2024 | 234 | $963.4M |
| Q3 2024 | 243 | $796.6M |
| Q2 2024 | 285 | $1.6B |
| Q1 2024 | 272 | $1.5B |
| Q4 2023 | 260 | $1.7B |